The DVSMCs were incubated with IL-17, IL-17, and IL-17 neutralizing antibodies, IL-17 and tanshinone IIA, SSc serum, SSc serum, and IL-17 neutralizing antibodies, and SSc serum and tanshinone IIA for 3 days. Here, IL17A is linked to systemic sclerosis.